Hiroya Taniguchi Selected Research

Stomach Neoplasms (Stomach Cancer)

10/2021	Circulating Tumor DNA Analysis Detects FGFR2 Amplification and Concurrent Genomic Alterations Associated with FGFR Inhibitor Efficacy in Advanced Gastric Cancer.
4/2020	Efficacy of Cytotoxic Agents After Progression on Anti-PD-(L)1 Antibody for Pre-treated Metastatic Gastric Cancer.
1/2020	Clinical and molecular factors for selection of nivolumab or irinotecan as third-line treatment for advanced gastric cancer.
1/2020	The Impact of Molecular Subtype on Efficacy of Chemotherapy and Checkpoint Inhibition in Advanced Gastric Cancer.
1/2020	Enhanced tumor response to radiotherapy after PD-1 blockade in metastatic gastric cancer.
1/2020	Improved efficacy of taxanes and ramucirumab combination chemotherapy after exposure to anti-PD-1 therapy in advanced gastric cancer.
1/2020	Emergence of Concurrent Multiple EGFR Mutations and MET Amplification in a Patient With EGFR-Amplified Advanced Gastric Cancer Treated With Cetuximab.
1/2020	A Phase II Study of Modified FOLFOX6 for Advanced Gastric Cancer Refractory to Standard Therapies.
1/2019	A Prospective Trial Evaluating the Safety of a Shortened Infusion of Ramucirumab in Patients with Gastrointestinal Cancer.
11/2018	Salvage chemotherapy with the combination of oxaliplatin, leucovorin, and 5-fluorouracil in advanced gastric cancer refractory or intolerant to fluoropyrimidines, platinum, taxanes, and irinotecan.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hiroya Taniguchi Research Topics

Disease

63	Colorectal Neoplasms (Colorectal Cancer) 03/2024 - 10/2013
48	Neoplasms (Cancer) 10/2023 - 10/2008
21	Stomach Neoplasms (Stomach Cancer) 10/2021 - 06/2010
9	Colonic Neoplasms (Colon Cancer) 01/2023 - 10/2008
8	Neutropenia 11/2023 - 01/2017
8	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2016
5	Febrile Neutropenia 11/2023 - 01/2017
5	Microsatellite Instability 01/2023 - 01/2020
5	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2023 - 01/2019
4	Adenocarcinoma 10/2023 - 01/2018
4	Disease Progression 01/2023 - 08/2011
3	Diarrhea 11/2020 - 08/2015
3	Esophageal Neoplasms (Esophageal Cancer) 10/2016 - 08/2011
2	Squamous Cell Carcinoma of Head and Neck 03/2024 - 12/2011
2	Mucositis 11/2020 - 08/2015
2	Sarcopenia 10/2018 - 06/2017
2	Nausea 01/2017 - 09/2016
2	Esophageal Squamous Cell Carcinoma 10/2016 - 08/2015
2	Prostatic Neoplasms (Prostate Cancer) 02/2011 - 11/2008
1	Nasopharyngeal Carcinoma 03/2024
1	Rectal Neoplasms (Rectal Cancer) 01/2023
1	Cutaneous Fistula 08/2022
1	Fistula 08/2022
1	Lymphatic Metastasis 04/2022
1	Leiomyosarcoma 12/2021

Drug/Important Bio-Agent (IBA)

21	Bevacizumab (Avastin)FDA Link 01/2024 - 02/2014
18	Irinotecan (Camptosar)FDA LinkGeneric 11/2023 - 06/2010
17	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2023 - 08/2012
15	Biomarkers (Surrogate Marker)IBA 01/2024 - 11/2014
14	Fluorouracil (Carac)FDA LinkGeneric 03/2024 - 08/2012
12	trifluridine tipiracil drug combinationIBA 01/2024 - 01/2017
10	Cetuximab (Erbitux)FDA Link 03/2024 - 09/2015
10	Circulating Tumor DNAIBA 01/2023 - 12/2020
9	Leucovorin (Folinic Acid)FDA Link 03/2023 - 08/2012
9	regorafenibIBA 01/2021 - 01/2017
8	Cisplatin (Platino)FDA LinkGeneric 03/2024 - 04/2009
6	Immune Checkpoint InhibitorsIBA 12/2021 - 01/2020
6	Panitumumab (Vectibix)FDA Link 06/2021 - 03/2016
6	ErbB Receptors (EGF Receptor)IBA 06/2021 - 04/2015
4	pembrolizumabIBA 03/2024 - 01/2020
4	Trastuzumab (Herceptin)FDA Link 01/2023 - 08/2017
4	NivolumabIBA 12/2021 - 11/2018
4	human ERBB2 proteinIBA 11/2021 - 08/2017
4	RamucirumabIBA 10/2021 - 01/2019
4	AntibodiesIBA 01/2019 - 01/2017
3	Growth Factor ReceptorsIBA 01/2023 - 03/2016
3	Capecitabine (Xeloda)FDA Link 12/2021 - 01/2021
3	Taxoids (Taxanes)IBA 01/2020 - 08/2012
3	BilirubinIBA 01/2019 - 01/2016
3	S-1 plus cisplatinIBA 08/2014 - 08/2012
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2011 - 10/2008
3	LigandsIBA 02/2011 - 10/2008
2	binimetinibIBA 03/2024 - 01/2020
2	encorafenibIBA 03/2024 - 01/2020
2	Gemcitabine FDA Link 03/2024 - 04/2009
2	Cell-Free Nucleic AcidsIBA 01/2024 - 10/2023
2	pertuzumabIBA 01/2023 - 11/2021
2	Monoclonal AntibodiesIBA 01/2023 - 06/2021
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2021 - 01/2018
2	Cytotoxins (Cytolysins)IBA 04/2020 - 08/2017
2	Antineoplastic Agents (Antineoplastics)IBA 03/2020 - 10/2012
2	Alanine Transaminase (SGPT)IBA 01/2020 - 01/2017
2	taxaneIBA 01/2019 - 09/2017
2	PlatinumIBA 11/2018 - 12/2011
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2017 - 01/2017
2	Docetaxel (Taxotere)FDA Link 08/2015 - 04/2009
1	B7-H1 AntigenIBA 03/2024
1	Angiogenesis InhibitorsIBA 01/2024
1	DNA (Deoxyribonucleic Acid)IBA 10/2023
1	Trifluridine (Viroptic)FDA LinkGeneric 01/2023
1	Notch ReceptorsIBA 10/2022
1	TAS-116IBA 12/2021
1	quinone (benzoquinone)IBA 11/2021
1	Oxidoreductases (Dehydrogenase)IBA 11/2021
1	napabucasinIBA 11/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2021
1	NAD (NADH)IBA 11/2021
1	Vascular Endothelial Growth Factor DIBA 10/2021
1	Tumor Biomarkers (Tumor Markers)IBA 07/2021
1	fms-Like Tyrosine Kinase 3IBA 01/2021
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2021
1	Phosphotransferases (Kinase)IBA 03/2020
1	TropomyosinIBA 03/2020
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 03/2020
1	Lipase (Acid Lipase)FDA Link 01/2020

Therapy/Procedure

42	Drug Therapy (Chemotherapy) 03/2024 - 04/2009
36	Therapeutics 03/2024 - 11/2008
6	Adjuvant Chemotherapy 01/2023 - 04/2015
3	Immunotherapy 09/2022 - 02/2020
3	Neoadjuvant Therapy 08/2022 - 08/2015
3	Combination Drug Therapy (Combination Chemotherapy) 01/2020 - 06/2010
3	Chemoradiotherapy 10/2016 - 08/2011
2	Hepatectomy 10/2021 - 08/2021
2	Drug Tapering 06/2017 - 08/2015
1	Ileostomy 08/2022
1	Colectomy 08/2022
1	Aftercare (After-Treatment) 04/2022
1	Lymph Node Excision (Lymph Node Dissection) 04/2022
1	Precision Medicine 11/2021
1	Radiotherapy 01/2020